Membership of the British Pharmacopoeia Commission

Xuất bản: UTC +7

Cập nhật lần cuối: UTC +7

DOWNLOAD FILE PDF:VIEWDOWNLOAD
Membership of the British Pharmacopoeia Commission

If you find any inaccurate information, please let us know by providing your feedback here

The list below includes those members who served during the period 2023 to 2024.

Chair

Dr Anna-Maria Brady BSc PhD

Former Head of Biologicals and Administration, Veterinary Medicines Directorate

Vice-Chair

Mr Robert Lowe BPharm FRPharmS

Director of Pharmacy Quality Assurance Specialist Services, NHS East of England & Northamptonshire

Dr Emre Amirak BSc MBBS MRCS

Country Medical Director UK & Ireland, Orphazyme A/S; President & Chief Medical Director, Vionelix Therapeutics

Dr Edward Bush BSc PhD

Principal Scientist – Pharmacopoeial Specialist, Chemical Development, AstraZeneca

Mr Carlo Emanuele Giartosio MSc

Former Regulatory Coordination & Scientific Support Manager, Merck Serono

Dr Alison Gleadle BSc PhD (Lay member)

Former Group Product Risk Director, Tesco Stores Ltd.

Dr Vikas Jaitely BPharm MPharm PhD MRPharmS GPhC MTOPRA

Director (EU Digital Healthcare & Devices), Global Regulatory Affairs, Merck

Mr Sean Jones BSc MSc MRPharmS

Former Expert Quality Assessor, MHRA; former Trust Quality Controller, Guy’s & St. Thomas’ NHS Foundation Trust

Dr Paul Marshall BPharm PhD MRPharmS MAPS FTOPRA

Director, Global Regulatory Affairs, Jazz Pharmaceuticals

Ms Sharon Palser MSc (Lay member)

Former Director of Development, NHS Plymouth

Mr James Rickard MPharm MRPharmS

Chief Scientific Officer, Richmond Pharmacology; Visiting Senior Lecturer, Kings College, London

Professor Monique Simmonds OBE JP BSc PhD FLS FBS FRES FWIF

Deputy Director of Science, Royal Botanic Gardens, Kew

Secretary and Scientific Director

Mr James Pound1 BSc

Deputy Director – Standards & Compliance, Healthcare Quality & Access, MHRA; former Group Manager, British Pharmacopoeia and Laboratory Services, MHRA

Mr Steve Hoare2 BSc

Head of Standards & Regulatory Governance, Healthcare Quality & Access, MHRA

1 Until 20 March 2023.

2 From 21 March 2023.

Leave a Reply

Your email address will not be published. Required fields are marked *